BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Treatment
20 results:

  • 1. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Pitfall in Thyroid Practice.
    Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
    Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
    Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
    J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Acquisition of Genetic Aberrations During the Progression of High-Grade Intraepithelial Lesions/Micro-Invasive Squamous cancers to Widely Invasive cervical Squamous Cell cancer.
    Kashofer K; Reich O; Regauer S
    Arch Pathol Lab Med; 2023 Dec; 147(12):1438-1445. PubMed ID: 36800542
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mutated hras Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck cancer.
    Jagadeeshan S; Prasad M; Badarni M; Ben-Lulu T; Liju VB; Mathukkada S; Saunders C; Shnerb AB; Zorea J; Yegodayev KM; Wainer M; Vtorov L; Allon I; Cohen O; Gausdal G; Friedmann-Morvinski D; Cheong SC; Ho AL; Rosenberg AJ; Kessler L; Burrows F; Kong D; Grandis JR; Gutkind JS; Elkabets M
    Cancer Res; 2023 Apr; 83(7):1031-1047. PubMed ID: 36753744
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Differential proteome and functional analysis of NSCLC cell lines in response to Tualang honey treatment.
    Amran N; Abdul-Rahman PS
    J Ethnopharmacol; 2022 Jul; 293():115264. PubMed ID: 35398242
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expression of miR-34a and miR-15b during the progression of cervical cancer in a murine model expressing the HPV16 E7 oncoprotein.
    Ocadiz-Delgado R; Cruz-Colin JL; Alvarez-Rios E; Torres-Carrillo A; Hernandez-Mendoza K; Conde-Pérezprina JC; Dominguez-Gomez GI; Garcia-Villa E; Lambert PF; Gariglio P
    J Physiol Biochem; 2021 Nov; 77(4):547-555. PubMed ID: 33937961
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. treatment of consistent BRAF/hras gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
    Guan J; Luo Z; Xiao Z; Xie Y; Lin L
    BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV
    Dorta-Estremera S; Hegde VL; Slay RB; Sun R; Yanamandra AV; Nicholas C; Nookala S; Sierra G; Curran MA; Sastry KJ
    J Immunother Cancer; 2019 Sep; 7(1):252. PubMed ID: 31533840
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028).
    Paik ES; Lim MC; Kim MH; Kim YH; Song ES; Seong SJ; Suh DH; Lee JM; Lee C; Choi CH
    Gynecol Oncol; 2019 Sep; 154(3):547-553. PubMed ID: 31272738
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hobnail Variant of Papillary Thyroid Carcinoma: Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases.
    Cameselle-Teijeiro JM; Rodríguez-Pérez I; Celestino R; Eloy C; Piso-Neira M; Abdulkader-Nallib I; Soares P; Sobrinho-Simões M
    Am J Surg Pathol; 2017 Jun; 41(6):854-860. PubMed ID: 28009606
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An integrated approach of network-based systems biology, molecular docking, and molecular dynamics approach to unravel the role of existing antiviral molecules against AIDS-associated cancer.
    Omer A; Singh P
    J Biomol Struct Dyn; 2017 May; 35(7):1547-1558. PubMed ID: 27484103
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients.
    Deutsch E; Haie-Meder C; Bayar MA; Mondini M; Laporte M; Mazeron R; Adam J; Varga A; Vassal G; Magné N; Chargari C; Lanoy E; Pautier P; Levy A; Soria JC
    Oncotarget; 2016 May; 7(18):25549-57. PubMed ID: 27016411
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.
    Luk PP; Weston JD; Yu B; Selinger CI; Ekmejian R; Eviston TJ; Lum T; Gao K; Boyer M; O'Toole SA; Clark JR; Gupta R
    Head Neck; 2016 Apr; 38 Suppl 1():E1838-47. PubMed ID: 26699379
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Gamma tocotrienol targets tyrosine phosphatase SHP2 in mammospheres resulting in cell death through RAS/ERK pathway.
    Gu W; Prasadam I; Yu M; Zhang F; Ling P; Xiao Y; Yu C
    BMC Cancer; 2015 Aug; 15():609. PubMed ID: 26315028
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Extraordinary response to crizotinib in a woman with squamous cell lung cancer after two courses of failed chemotherapy.
    Wang Q; He Y; Yang X; Wang Y; Xiao H
    BMC Pulm Med; 2014 May; 14():83. PubMed ID: 24885608
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Phospholipase A/Acyltransferase enzyme activity of H-rev107 inhibits the H-RAS signaling pathway.
    Wang CH; Shyu RY; Wu CC; Tsai TC; Wang LK; Chen ML; Jiang SY; Tsai FM
    J Biomed Sci; 2014 May; 21(1):36. PubMed ID: 24884338
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. k-ras resides on the Arf6-mediated CIE system and its active type interacted with Arf6T27N.
    Xie CG; Wei SM; Cai JT
    Cell Signal; 2012 Feb; 24(2):524-531. PubMed ID: 22033036
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetic alterations in the k-ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy.
    Wegman P; Ahlin C; Sorbe B
    Int J Gynecol Cancer; 2011 Jan; 21(1):86-91. PubMed ID: 21330833
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Tumor markers useful in the diagnostics and monitoring of endometrial and cervical cancer].
    Bedkowska GE; Lawicki S; Szmitkowski M
    Postepy Hig Med Dosw (Online); 2007; 61():122-8. PubMed ID: 17369780
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The relevance of oncogenes as prognostic markers in cervical cancer.
    Soh LT; Heng D; Lee IW; Ho TH; Hui KM
    Int J Gynecol Cancer; 2002; 12(5):465-74. PubMed ID: 12366664
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.